71 related articles for article (PubMed ID: 2847749)
21. Allosteric interaction between the site labeled by [3H]imipramine and the serotonin transporter in human platelets.
Meyerson LR; Ieni JR; Wennogle LP
J Neurochem; 1987 Feb; 48(2):560-5. PubMed ID: 3491878
[TBL] [Abstract][Full Text] [Related]
22. Modulation of neuronal serotonin uptake by a putative endogenous ligand of imipramine recognition sites.
Barbaccia ML; Gandolfi O; Chuang DM; Costa E
Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5134-8. PubMed ID: 6308674
[TBL] [Abstract][Full Text] [Related]
23. [Effects, in rats, of metapramine and carpipramine on the uptake of catecholamines and serotonin; relationship with 3H-imipramine binding].
Dagonneau H; Fonlupt P; Pacheco H
C R Seances Soc Biol Fil; 1986; 180(1):43-8. PubMed ID: 3017518
[TBL] [Abstract][Full Text] [Related]
24. Personality features and platelet 3H-imipramine binding.
Castrogiovanni P; Maremmani I; Di Muro A; Rotondo A; Marazziti D
Neuropsychobiology; 1992; 25(1):11-3. PubMed ID: 1318512
[TBL] [Abstract][Full Text] [Related]
25. Autoradiographic characterization of [3H]imipramine and [3H]citalopram binding in rat and human brain: species differences and relationships to serotonin innervation patterns.
Duncan GE; Little KY; Kirkman JA; Kaldas RS; Stumpf WE; Breese GR
Brain Res; 1992 Sep; 591(2):181-97. PubMed ID: 1332802
[TBL] [Abstract][Full Text] [Related]
26. Serotonin uptake and imipramine binding in rat platelets after chronic dexamethasone and amitriptyline treatment.
Chan MY; Lee PH
Pharmacol Res Commun; 1985 Jul; 17(7):619-32. PubMed ID: 2996030
[TBL] [Abstract][Full Text] [Related]
27. Similarities and differences between high-affinity binding sites for cocaine and imipramine in mouse cerebral cortex.
Reith ME; Allen DL; Sershen H; Lajtha A
J Neurochem; 1984 Jul; 43(1):249-55. PubMed ID: 6726250
[TBL] [Abstract][Full Text] [Related]
28. Solubilization and partial purification of the high affinity [3H] imipramine binding site from human platelets.
Rehavi M; Skolnick P; Paul SM
FEBS Lett; 1982 Dec; 150(2):514-8. PubMed ID: 6297983
[No Abstract] [Full Text] [Related]
29. [The nature of the interactions of imipramine and serotonin with human lymphocytes].
Lesnichuk SA; Katukov VIu; Porodenko NV
Eksp Klin Farmakol; 1997; 60(6):40-3. PubMed ID: 9460597
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of [3H]imipramine binding and [3H]5-HT uptake in human platelets by some natural indoleamine and catecholamine aldehyde condensation products.
Brusov OS; Fomenko AM; Katasonov AB
Eur J Pharmacol; 1984 Aug; 103(1-2):191-2. PubMed ID: 6090176
[No Abstract] [Full Text] [Related]
31. Unaltered platelet [3H]-imipramine binding in dementia of the Alzheimer type.
Weizman R; Dick J; Mosek A; Tyano S; Rehavi M
Neuropsychobiology; 1988; 19(2):69-72. PubMed ID: 2852311
[TBL] [Abstract][Full Text] [Related]
32. Molecular aspects of the imipramine 'receptor'.
Davis A
Experientia; 1984 Aug; 40(8):783-94. PubMed ID: 6088274
[No Abstract] [Full Text] [Related]
33. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
Norman AB; Creese I
Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
[TBL] [Abstract][Full Text] [Related]
34. Imipramine binding sites in brain and platelets: role in affective disorders.
Hrdina PD
Int J Clin Pharmacol Res; 1989; 9(2):119-22. PubMed ID: 2541089
[TBL] [Abstract][Full Text] [Related]
35. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.
D'Amato RJ; Largent BL; Snowman AM; Snyder SH
J Pharmacol Exp Ther; 1987 Jul; 242(1):364-71. PubMed ID: 3475452
[TBL] [Abstract][Full Text] [Related]
36. Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes.
Rojansky N; Halbreich U; Zander K; Barkai A; Goldstein S
Gynecol Obstet Invest; 1991; 31(3):146-52. PubMed ID: 1649111
[TBL] [Abstract][Full Text] [Related]
37. [Binding of tritiated imipramine to human platelets. 1 or several binding sites?].
Scotto di Tella AM; Levy C; Lacarelle B; Tissot R
Encephale; 1986; 12(1):13-7. PubMed ID: 3009134
[TBL] [Abstract][Full Text] [Related]
38. Platelet markers in suicide attempters.
Marazziti D; Presta S; Silvestri S; Battistini A; Mosti L; Balestri C; Palego L; Conti L
Prog Neuropsychopharmacol Biol Psychiatry; 1995 May; 19(3):375-83. PubMed ID: 7624489
[TBL] [Abstract][Full Text] [Related]
39. Specific binding sites for cyclic antidepressants.
Mellerup ET; Plenge P
Acta Pharmacol Toxicol (Copenh); 1985; 56 Suppl 1():154-61. PubMed ID: 2984884
[No Abstract] [Full Text] [Related]
40. Increased platelet 3H-imipramine binding and monoamine oxidase B activity in Alzheimer's disease.
Bonuccelli U; Piccini P; Marazziti D; Cassano GB; Muratorio A
J Neural Transm Park Dis Dement Sect; 1990; 2(2):139-47. PubMed ID: 2222781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
